Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001964306-25-000141
Filing Date
2025-03-07
Accepted
2025-03-07 16:26:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2937
  Complete submission text file 0001964306-25-000141.txt   4379
Mailing Address 202 CARNEGIE CENTER SUITE 301 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 301 PRINCETON NJ 08540 646-885-8505
Y-mAbs Therapeutics, Inc. (Subject) CIK: 0001722964 (see all company filings)

EIN.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38650 | Film No.: 25720485
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169
Business Address
Rossi Michael J (Reporting) CIK: 0001948795 (see all company filings)

Type: 144